Kiniksa Pharmaceuticals International, plc Class A

1. 01

   2.4% below its 52-week high

   Closed at $96.12 on 4 Nov 2026: 2.4% below the 52-week high of $98.48 (30 Oct 2026) and 159.6% above the low of $37.02 (15 Jan 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

2. 02

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +24.7% (SPY −1.6%, XLV +13.5%). 3 months: +23.1% (SPY −0.4%, XLV +15.5%). 1 year: +149.4% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: KNSA, SPY and XLV · as of 4 Nov 2026

3. 03

   6.8 days to cover short interest

   3.8M shares were sold short at the 15 Oct 2026 settlement, 7.7% of the 48.8M shares outstanding; covering them would take 6.8 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

4. 04

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $96.12 was 20.2% above its 50-day average ($79.99) and 57.5% above its 200-day average ($61.01). It has closed above the 200-day for 383 sessions, since 29 Apr 2025. The 50-day average crossed above the 200-day on 15 May 2025, 370 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

At the 4 Nov 2026 close